PrEP Eligibility Based on HIV Status
Determine HIV status and patient’s eligibility for PrEP using this flowchart.
Infectious Disease
Community Acquired Pneumonia Guidelines
Diagnose, treat, and prevent community acquired pneumonia using key recommendations from the IDSA/ATS CAP guidelines.
Fetroja Approved for Hospital-Acquired, Ventilator-Associated Bacterial Pneumonia
The FDA has approved Fetroja® (cefiderocol; Shionogi) for the treatment of adult patients with HABP/VABP caused by susceptible Gram-negative pathogens.
Evaluating Replication Competence and Immune Response to Adenovirus Type 7 In Pediatric Populations
Researchers compared HAdV-3 with HAdV-7 replication kinetics and host response in ex vivo human lung tissue cultures.
Infection Risk Low in Patients With PJI and Concomitant Asymptomatic Prosthetic Implants
There is a low incidence of second PJI in patients with bacteremia or hematogenous periprosthetic joint infection with concomitant prosthetic implants.
Health Inequity in the Hispanic/Latinx Population During the COVID-19 Pandemic
As SARS-CoV-2 has spread around the world, major health disparities have become apparent among patients with COVID-19, particularly in the Hispanic/Latinx community.
Redefining the Cutoff Duration for Staphylococcus aureus Persistent Bacteremia
Investigators assessed patients who hospitalized with microbial S aureus bacteremia to determine the most meaningful cutoff point to define S aureus persistent bacteremia.
Evidence for Functional, Persistent SARS-CoV-2-Specific Immune Memory
Researchers sought to determine whether individuals recovered from mildly symptomatic COVID-19 develop and sustain immunological memory against the SARS-CoV-2 virus.
S aureus Bloodstream Infection Linked to Risk for Myocardial Infarction
Investigators analyzed a potential link between community-acquired Staphylococcus aureus bloodstream infection and increased short-term risk for myocardial infarction, which is associated with subsequent mortality.
Generic Version of Ciprodex Otic Suspension Now Available
The otic suspension is a combination of ciprofloxacin, a fluoroquinolone antibacterial and dexamethasone, a corticosteroid.
-
Loading...
-
Loading...
